PMID33212010

Krug, K., Jaehnig, E. J., Satpathy, S., Blumenberg, L., Karpova, A., Anurag, M., Miles, G., Mertins, P., Geffen, Y., Tang, L. C., Heiman, D. I., Cao, S., Maruvka, Y. E., Lei, J. T., Huang, C., Kothadia, R. B., Colaprico, A., Birger, C., Wang, J., Dou, Y., Wen, B., Shi, Z., Liao, Y., Wiznerowicz, M., Wyczalkowski, M. A., Chen, X. S., Kennedy, J. J., Paulovich, A. G., Thiagarajan, M., Kinsinger, C. R., Hiltke, T., Boja, E. S., Mesri, M., Robles, A. I., Rodriguez, H., Westbrook, T. F., Ding, L., Getz, G., Clauser, K. R., Fenyƶ, D., Ruggles, K. V., Zhang, B., Mani, D. R., Carr, S. A., Ellis, M. J., Gillette, M. A. and Clinical Proteomic Tumor Analysis, Consortium. (2020). Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy. Cell. 183, 1436-1456.e31. [PubMed]